Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention
Abstract Introduction The cost benefit of intercostal nerve cryoablation during surgical lobectomy for postoperative pain management is unknown. The current study compared hospital economics, resource use, and clinical outcomes during the index stay and accompanying short-term follow-up. Patients wh...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-12-01
|
| Series: | Pain and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40122-024-00694-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586070081929216 |
|---|---|
| author | Daniel L. Miller Jacob Hutchins Michael A. Ferguson Yazid Barhoush Emily Achter John P. Kuckelman |
| author_facet | Daniel L. Miller Jacob Hutchins Michael A. Ferguson Yazid Barhoush Emily Achter John P. Kuckelman |
| author_sort | Daniel L. Miller |
| collection | DOAJ |
| description | Abstract Introduction The cost benefit of intercostal nerve cryoablation during surgical lobectomy for postoperative pain management is unknown. The current study compared hospital economics, resource use, and clinical outcomes during the index stay and accompanying short-term follow-up. Patients who underwent lobectomy with standard of care treatment for postsurgical pain management and cryoablation were compared to those with standard of care treatment only. We hypothesized that cryoablation would reduce narcotic use and index hospital and short-term costs. Methods A retrospective, propensity matched cohort of surgical patients treated between 2016 and 2022 from a US National All-Payer Database were used. Cost and outcome comparisons were made between groups using chi-square and t tests. Results From a cohort of 23,138 patients, 266 pairs with a mean age of 69 years were included. Matching variables included age, gender, lobe resected, and prior opioid use. Both groups had significant comorbidity history and prior opioid use; 66% (n = 175 both groups) underwent open lobectomy and 53% (n = 142 vs. 143) had the upper lobe resected. Cryoablation intervention was associated with 1.3 days reduced hospital stay (8.8 vs. 10.1 days, p = 0.31) and no difference in perioperative safety. After 90 days, postsurgery cryoablation patients had lower opioid prescription refills (27.3 vs. 36.9 morphine milligram equivalents, p = 0.03). Cryoablation patient costs trended less than non-cryoablation patients during index ($38,753 vs. $43,974, p = 0.10) and lower through 6 months (total costs, $65,703 vs. $74,304, p = 0.10). There was no difference in postsurgery resource use, but a smaller proportion of cryoablation patients had outpatient hospital visits (83.1%, N = 221 vs. 92.9%, n = 247, p < 0.01). Conclusion Cryoablation during lobectomy is safe and does not add incremental hospital costs. Clinical meaningful reductions in length of stay and postsurgery opioid use were observed with cryoablation intervention. The addition of cryoablation during surgery to reduce postoperative pain appears to be a cost-effective therapy. |
| format | Article |
| id | doaj-art-82be7800efcf43b3a1e17c30cec4b387 |
| institution | Kabale University |
| issn | 2193-8237 2193-651X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Pain and Therapy |
| spelling | doaj-art-82be7800efcf43b3a1e17c30cec4b3872025-01-26T12:13:50ZengAdis, Springer HealthcarePain and Therapy2193-82372193-651X2024-12-0114131732810.1007/s40122-024-00694-3Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective InterventionDaniel L. Miller0Jacob Hutchins1Michael A. Ferguson2Yazid Barhoush3Emily Achter4John P. Kuckelman5Medical College GeorgiaUniversity MinnesotaAtriCureSTATinMED, LLCSTATinMED, LLCMedical College GeorgiaAbstract Introduction The cost benefit of intercostal nerve cryoablation during surgical lobectomy for postoperative pain management is unknown. The current study compared hospital economics, resource use, and clinical outcomes during the index stay and accompanying short-term follow-up. Patients who underwent lobectomy with standard of care treatment for postsurgical pain management and cryoablation were compared to those with standard of care treatment only. We hypothesized that cryoablation would reduce narcotic use and index hospital and short-term costs. Methods A retrospective, propensity matched cohort of surgical patients treated between 2016 and 2022 from a US National All-Payer Database were used. Cost and outcome comparisons were made between groups using chi-square and t tests. Results From a cohort of 23,138 patients, 266 pairs with a mean age of 69 years were included. Matching variables included age, gender, lobe resected, and prior opioid use. Both groups had significant comorbidity history and prior opioid use; 66% (n = 175 both groups) underwent open lobectomy and 53% (n = 142 vs. 143) had the upper lobe resected. Cryoablation intervention was associated with 1.3 days reduced hospital stay (8.8 vs. 10.1 days, p = 0.31) and no difference in perioperative safety. After 90 days, postsurgery cryoablation patients had lower opioid prescription refills (27.3 vs. 36.9 morphine milligram equivalents, p = 0.03). Cryoablation patient costs trended less than non-cryoablation patients during index ($38,753 vs. $43,974, p = 0.10) and lower through 6 months (total costs, $65,703 vs. $74,304, p = 0.10). There was no difference in postsurgery resource use, but a smaller proportion of cryoablation patients had outpatient hospital visits (83.1%, N = 221 vs. 92.9%, n = 247, p < 0.01). Conclusion Cryoablation during lobectomy is safe and does not add incremental hospital costs. Clinical meaningful reductions in length of stay and postsurgery opioid use were observed with cryoablation intervention. The addition of cryoablation during surgery to reduce postoperative pain appears to be a cost-effective therapy.https://doi.org/10.1007/s40122-024-00694-3Medicare claimsCancerCost-effectiveCryoablationLobectomyOpioids |
| spellingShingle | Daniel L. Miller Jacob Hutchins Michael A. Ferguson Yazid Barhoush Emily Achter John P. Kuckelman Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention Pain and Therapy Medicare claims Cancer Cost-effective Cryoablation Lobectomy Opioids |
| title | Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention |
| title_full | Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention |
| title_fullStr | Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention |
| title_full_unstemmed | Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention |
| title_short | Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention |
| title_sort | intercostal nerve cryoablation during lobectomy for postsurgical pain a safe and cost effective intervention |
| topic | Medicare claims Cancer Cost-effective Cryoablation Lobectomy Opioids |
| url | https://doi.org/10.1007/s40122-024-00694-3 |
| work_keys_str_mv | AT daniellmiller intercostalnervecryoablationduringlobectomyforpostsurgicalpainasafeandcosteffectiveintervention AT jacobhutchins intercostalnervecryoablationduringlobectomyforpostsurgicalpainasafeandcosteffectiveintervention AT michaelaferguson intercostalnervecryoablationduringlobectomyforpostsurgicalpainasafeandcosteffectiveintervention AT yazidbarhoush intercostalnervecryoablationduringlobectomyforpostsurgicalpainasafeandcosteffectiveintervention AT emilyachter intercostalnervecryoablationduringlobectomyforpostsurgicalpainasafeandcosteffectiveintervention AT johnpkuckelman intercostalnervecryoablationduringlobectomyforpostsurgicalpainasafeandcosteffectiveintervention |